Search Results

There are 19598 results for: content related to: Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis

  1. Topical pimecrolimus for eczema

    Intervention Review

    The Cochrane Library

    Darren M Ashcroft, Li-Chia Chen, Ruth Garside, Ken Stein and Hywel C Williams

    Published Online : 17 OCT 2007, DOI: 10.1002/14651858.CD005500.pub2

  2. Pimecrolimus: A review

    Journal of the European Academy of Dermatology and Venereology

    Volume 17, Issue 5, September 2003, Pages: 493–503, AK Gupta and M Chow

    Version of Record online : 27 AUG 2003, DOI: 10.1046/j.1468-3083.2003.00692.x

  3. You have full text access to this OnlineOpen article
    Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants

    Pediatric Allergy and Immunology

    Volume 26, Issue 4, June 2015, Pages: 306–315, Thomas Luger, Mark Boguniewicz, Warner Carr, Michael Cork, Mette Deleuran, Lawrence Eichenfield, Philippe Eigenmann, Regina Fölster-Holst, Carlo Gelmetti, Harald Gollnick, Eckard Hamelmann, Adelaide A. Hebert, Antonella Muraro, Arnold P. Oranje, Amy S. Paller, Carle Paul, Luis Puig, Johannes Ring, Elaine Siegfried, Jonathan M. Spergel, Georg Stingl, Alain Taieb, Antonio Torrelo, Thomas Werfel and Ulrich Wahn

    Version of Record online : 13 APR 2015, DOI: 10.1111/pai.12331

  4. The role of topical calcineurin inhibitors in atopic dermatitis:

    British Journal of Dermatology

    Volume 151, Issue s70, December 2004, Pages: 3–27, A. Alomar, J. Berth-Jones, J.D. Bos, A. Giannetti, S. Reitamo, T. Ruzicka, J-F. Stalder, K. Thestrup-Pedersen and (EUROPEAN WORKING GROUP ON ATOPIC DERMATITIS)

    Version of Record online : 17 NOV 2004, DOI: 10.1111/j.1365-2133.2004.06269.x

  5. Retracted: Meta-analysis on the comparison between two topical calcineurin inhibitors in atopic dermatitis

    The Journal of Dermatology

    Volume 39, Issue 6, June 2012, Pages: 520–526, Zhi Qiang YIN, Wei Ming ZHANG, Guo Xin SONG and Dan LUO

    Version of Record online : 12 MAR 2012, DOI: 10.1111/j.1346-8138.2012.01529.x

    Corrected by:

    Retraction: Retraction

    Vol. 40, Issue 5, 418, Version of Record online: 14 MAY 2013

  6. You have free access to this content
    Pimecrolimus – an anti-inflammatory drug targeting the skin

    Experimental Dermatology

    Volume 13, Issue 12, December 2004, Pages: 721–730, M. Grassberger, M. Steinhoff, D. Schneider and T. A. Luger

    Version of Record online : 18 NOV 2004, DOI: 10.1111/j.0906-6705.2004.00269.x

  7. P-1 Allergy

    Journal of the European Academy of Dermatology and Venereology

    Volume 15, Issue s2, November 2001, Pages: 104–274,

    Version of Record online : 18 JUL 2008, DOI: 10.1111/j.1468-3083.2001.00001.x

  8. A cost-utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema

    British Journal of Dermatology

    Volume 154, Issue 6, June 2006, Pages: 1137–1146, M. Pitt, R. Garside and K. Stein

    Version of Record online : 14 MAR 2006, DOI: 10.1111/j.1365-2133.2006.07184.x

  9. Pimecrolimus in dermatology: atopic dermatitis and beyond

    International Journal of Clinical Practice

    Volume 59, Issue 8, August 2005, Pages: 969–974, Paolo Gisondi, 1 Charles N. Ellis and 2 Giampiero Girolomoni 3

    Version of Record online : 14 JUL 2005, DOI: 10.1111/j.1368-5031.2005.00587.x

  10. Effect of pimecrolimus vs. corticosteroids on murine bone marrow-derived dendritic cell differentiation, maturation and function

    Experimental Dermatology

    Volume 15, Issue 1, January 2006, Pages: 43–50, Mathias B. W. Krummen, Georg Varga, Meike Steinert, Anton Stuetz, Thomas A. Luger and Stephan Grabbe

    Version of Record online : 7 DEC 2005, DOI: 10.1111/j.0906-6705.2005.00395.x

  11. Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: Results of a randomized, double-blind, vehicle-controlled study

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 4, Issue 11, November 2006, Pages: 942–946, Markus Dawid, Marge Veensalu, Maximilian Grassberger and Klaus Wolff

    Version of Record online : 25 OCT 2006, DOI: 10.1111/j.1610-0387.2006.06124.x

  12. A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea

    Journal of the European Academy of Dermatology and Venereology

    Volume 22, Issue 6, June 2008, Pages: 729–734, AA Karabulut, B Izol Serel and HM Eksioglu

    Version of Record online : 4 MAR 2008, DOI: 10.1111/j.1468-3083.2008.02589.x

  13. Topical pimecrolimus and tacrolimus do not accelerate photocarcinogenesis in hairless mice after UVA or simulated solar radiation

    Experimental Dermatology

    Volume 18, Issue 3, March 2009, Pages: 246–251, Catharina M. Lerche, Peter A. Philipsen, Thomas Poulsen and Hans Christian Wulf

    Version of Record online : 28 JAN 2009, DOI: 10.1111/j.1600-0625.2008.00812.x

  14. Pimecrolimus 1% cream for oral erosive lichen planus: a 6-week randomized, double-blind, vehicle-controlled study with a 6-week open-label extension to assess efficacy and safety

    Journal of the European Academy of Dermatology and Venereology

    Volume 25, Issue 9, September 2011, Pages: 1061–1067, C. McCaughey, M. Machan, R. Bennett, J.J. Zone and C.M. Hull

    Version of Record online : 22 DEC 2010, DOI: 10.1111/j.1468-3083.2010.03923.x

  15. Pimecrolimus cream 1% in erosive oral lichen planus— a prospective randomized double-blind vehicle-controlled study

    British Journal of Dermatology

    Volume 159, Issue 4, October 2008, Pages: 936–941, T. Volz, U. Caroli, H. Lüdtke, M. Bräutigam, H. Kohler-Späth, M. Röcken and T. Biedermann

    Version of Record online : 21 JUL 2008, DOI: 10.1111/j.1365-2133.2008.08726.x

  16. Pimecrolimus versus placebo in genital aphthous ulcers of Behcet’s disease: a randomized double-blind controlled trial

    International Journal of Rheumatic Diseases

    Volume 13, Issue 3, August 2010, Pages: 253–258, Cheyda CHAMS-DAVATCHI, Behrooz BARIKBIN, Farhad SHAHRAM, Abdolhadi NADJI, Maryam MOGHADDASSI, Maryam YOUSEFI and Fereydoun DAVATCHI

    Version of Record online : 25 MAY 2010, DOI: 10.1111/j.1756-185X.2010.01531.x

  17. You have free access to this content
    Topical tacrolimus for atopic dermatitis

    Intervention Review

    The Cochrane Library

    Jade Cury Martins, Ciro Martins, Valeria Aoki, Aecio FT Gois, Henrique A Ishii and Edina MK da Silva

    Published Online : 1 JUL 2015, DOI: 10.1002/14651858.CD009864.pub2

  18. Blood concentrations, tolerability and efficacy of pimecrolimus cream 1% in Japanese infants and children with atopic dermatitis

    The Journal of Dermatology

    Volume 34, Issue 4, April 2007, Pages: 231–236, Lawrence F. EICHENFIELD, Vincent HO, Janice MATSUNAGA, Patricia LECLERC, Carle PAUL and Jon M. HANIFIN

    Version of Record online : 9 MAR 2007, DOI: 10.1111/j.1346-8138.2007.00259.x

  19. POSTERS

    Journal of the European Academy of Dermatology and Venereology

    Volume 19, Issue s2, November 2005, Pages: 1–411,

    Version of Record online : 27 SEP 2005, DOI: 10.1111/j.1468-3083.2005.01311.x

  20. Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial

    British Journal of Dermatology

    Volume 158, Issue 5, May 2008, Pages: 1083–1093, H. Gollnick, R. Kaufmann, D. Stough, H. Heikkila, K. Andriano, A. Grinienko, P. Jimenez and Pimecrolimus Cream 1% in (adult) Eczema: Prevention of Progression Multicentre Investigator Study Group

    Version of Record online : 13 MAR 2008, DOI: 10.1111/j.1365-2133.2008.08484.x